文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹

英国生物银行参与者中瘢痕疙瘩与增生性瘢痕的共病研究

Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank.
PubMed 文献 · JAMA Dermatol · 2023-01-01

该多中心横断面人群队列研究利用英国生物银行230078名有初级保健记录参与者的数据,采用logistic回归和全表型关联研究(PheWAS)分析过度瘢痕的共病。在972例过度瘢痕者中,证实了高血压、特应性湿疹等已知共病,并发现110个显著关联,涉及多个疾病系统。

要点

  • 在调整年龄、性别和 ethnicity 后,过度瘢痕与特应性湿疹的关联有统计学意义(OR 1.68,95%CI 1.36-2.07,P<.001)。
  • Black 参与者中过度瘢痕与高血压相关(OR 2.05,95%CI 1.13-3.72,P=.02);Asian 参与者中与维生素D缺乏相关(OR 2.24,95%CI 1.26-3.97,P=.006)。
  • PheWAS 发现110个显著关联,非皮肤科系统中肌肉骨骼疾病和疼痛症状突出。

核心结论

  • 该横断面研究在英国生物银行中验证了过度瘢痕的共病,并记录了额外的全表型关联,将作为未来研究共同病理生理机制的参考。

研究设计与样本

  • 多中心横断面人群队列研究,使用英国生物银行数据,拟合logistic回归模型检验过度瘢痕与包括1518个系统定义疾病类别在内的结局的关联。
  • 在502701名英国生物银行参与者中,分析限制于230078名有链接初级保健记录者。
  • 根据自我报告的 ethnicity(按英国生物银行定义)进行亚组建模。

主要发现

  • 972例过度瘢痕者中女性比例高于229106名对照(65% vs 55%),White ethnicity比例较低(86% vs 95%);总队列平均(SD)年龄为64(8)岁。
  • 在调整年龄、性别和 ethnicity 的模型中,过度瘢痕与高血压和特应性湿疹存在关联;特应性湿疹关联(OR 1.68,95%CI 1.36-2.07,P<.001)在调整额外潜在混杂因素后仍有统计学意义。
  • 完全调整模型在 ethnic 组内显示:Black 参与者中与高血压相关(OR 2.05,95%CI 1.13-3.72,P=.02);Asian 参与者中与维生素D缺乏相关(OR 2.24,95%CI 1.26-3.97,P=.006)。
  • Black 女性中与子宫平滑肌瘤的关联为边缘显著(OR 1.93,95%CI 1.00-3.71,P=.05);特应性湿疹关联在 White 参与者中显著(OR 1.68,95%CI 1.34-2.12,P<.001),在 Asian(OR 2.17,95%CI 1.01-4.67,P=.048)和 Black 参与者(OR 1.89,95%CI 0.83-4.28,P=.13)中显示相似趋势。
  • PheWAS 识别出跨疾病系统的110个显著关联;非皮肤科系统中肌肉骨骼疾病和疼痛症状突出。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Keloids and hypertrophic scars (excessive scarring) are relatively understudied disfiguring chronic skin conditions with high treatment resistance. OBJECTIVE: To evaluate established comorbidities of excessive scarring in European individuals, with comparisons across ethnic groups, and to identify novel comorbidities via a phenome-wide association study (PheWAS). DESIGN, SETTING, AND PARTICIPANTS: This multicenter cross-sectional population-based cohort study used UK Biobank (UKB) data and fitted logistic regression models for testing associations between excessive scarring and a variety of outcomes, including previously studied comorbidities and 1518 systematically defined disease categories. Additional modeling was performed within subgroups of participants defined by self-reported ethnicity (as defined in UK Biobank). Of 502 701 UKB participants, analyses were restricted to 230078 individuals with linked primary care records. EXPOSURES: Keloid or hypertrophic scar diagnoses. MAIN OUTCOMES AND MEASURES: Previously studied disease associations (hypertension, uterine leiomyoma, vitamin D deficiency, atopic eczema) and phenotypes defined in the PheWAS Catalog. RESULTS: Of the 972 people with excessive scarring, there was a higher proportion of female participants compared with the 229 106 controls (65% vs 55%) and a lower proportion of White ethnicity (86% vs 95%); mean (SD) age of the total cohort was 64 (8) years. Associations were identified with hypertension and atopic eczema in models accounting for age, sex, and ethnicity, and the association with atopic eczema (odds ratio [OR], 1.68; 95% CI, 1.36-2.07; P < .001) remained statistically significant after accounting for additional potential confounders. Fully adjusted analyses within ethnic groups revealed associations with hypertension in Black participants (OR, 2.05; 95% CI, 1.13-3.72; P = .02) and with vitamin D deficiency in Asian participants (OR, 2.24; 95% CI, 1.26-3.97; P = .006). The association with uterine leiomyoma was borderline significant in Black women (OR, 1.93; 95% CI, 1.00-3.71; P = .05), whereas the association with atopic eczema was significant in White participants (OR, 1.68; 95% CI, 1.34-2.12; P < .001) and showed a similar trend in Asian (OR, 2.17; 95% CI, 1.01-4.67; P = .048) and Black participants (OR, 1.89; 95% CI, 0.83-4.28; P = .13). The PheWAS identified 110 significant associations across disease systems; of the nondermatological, musculoskeletal disease and pain symptoms were prominent. CONCLUSIONS AND RELEVANCE: This cross-sectional study validated comorbidities of excessive scarring in UKB with comprehensive coverage of health outcomes. It also documented additional phenome-wide associations that will serve as a reference for future studies to investigate common underlying pathophysiologic mechanisms.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Ung CY, Warwick A, Onoufriadis A, et al. Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank. JAMA Dermatol. 2023. PMID: 36598763. doi:10.1001/jamadermatol.2022.5607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。